Last 12 months
Inside the activity.
2 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 04, 2022 Filed May 6, 2022 00:52 UTC |
Telman Deborah HEVP GC & Corporate Secretary
|
Tax withholdingCommon Stock | 1,299 | $32.44 | $42,139.56 |
DisclosureSEC source: 0001104659-22-056633 · tm2214603-9_4seq1.xml · nonDerivative · entry 2 Telman Deborah H · CIK 0001860008 · EVP GC & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,688 Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:52 UTC |
Telman Deborah HEVP GC & Corporate Secretary
|
Exercise / conversionCommon Stock | 4,431 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-056633 · tm2214603-9_4seq1.xml · nonDerivative · entry 1 Telman Deborah H · CIK 0001860008 · EVP GC & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:53 UTC |
WALSH MATTHEW MChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-056635 · tm2214603-10_4seq1.xml · derivative · entry 3 WALSH MATTHEW M · CIK 0001269428 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,310 Underlying: Common Stock · 8,310 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. F2 · derivative.exercise_date: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. F2 · derivative.expiration_date: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:53 UTC |
WALSH MATTHEW MChief Financial Officer
|
Tax withholdingCommon Stock | 2,847 | $32.44 | $92,356.68 |
DisclosureSEC source: 0001104659-22-056635 · tm2214603-10_4seq1.xml · nonDerivative · entry 2 WALSH MATTHEW M · CIK 0001269428 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,153 Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:53 UTC |
WALSH MATTHEW MChief Financial Officer
|
Exercise / conversionCommon Stock | 8,310 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-056635 · tm2214603-10_4seq1.xml · nonDerivative · entry 1 WALSH MATTHEW M · CIK 0001269428 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 04, 2022 Filed May 5, 2022 20:51 UTC |
Stahler Rachel AChief Information Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-056632 · tm2214603-8_4seq1.xml · derivative · entry 3 Stahler Rachel A · CIK 0001679854 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3.046 Underlying: Common Stock · 3,046 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. F2 · shares: The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations. F3 · derivative.exercise_date: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. F3 · derivative.expiration_date: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. Read SEC document |
| May 04, 2022 Filed May 5, 2022 20:51 UTC |
Stahler Rachel AChief Information Officer
|
Tax withholdingCommon Stock | 1,044 | $32.44 | $33,867.36 |
DisclosureSEC source: 0001104659-22-056632 · tm2214603-8_4seq1.xml · nonDerivative · entry 2 Stahler Rachel A · CIK 0001679854 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,476 Read SEC document |
| May 04, 2022 Filed May 5, 2022 20:51 UTC |
Stahler Rachel AChief Information Officer
|
Exercise / conversionCommon Stock | 3,046 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-056632 · tm2214603-8_4seq1.xml · nonDerivative · entry 1 Stahler Rachel A · CIK 0001679854 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:50 UTC |
Ritter Geralyn SHd of Ext. Affairs and ESG
|
Exercise / conversionRestricted Stock Units · Derivative | 1,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-056631 · tm2214603-7_4seq1.xml · derivative · entry 6 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,939 Underlying: Common Stock · 1,939 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. F2 · derivative.exercise_date: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. F2 · derivative.expiration_date: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:50 UTC |
Ritter Geralyn SHd of Ext. Affairs and ESG
|
Tax withholdingCommon Stock | 665 | $32.44 | $21,572.60 |
DisclosureSEC source: 0001104659-22-056631 · tm2214603-7_4seq1.xml · nonDerivative · entry 4 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,026 Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:50 UTC |
Ritter Geralyn SHd of Ext. Affairs and ESG
|
Exercise / conversionCommon Stock | 1,939 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-056631 · tm2214603-7_4seq1.xml · nonDerivative · entry 3 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:49 UTC |
Nisita VittorioHead of Global Business Svcs
|
Exercise / conversionRestricted Stock Units · Derivative | 2,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-056630 · tm2214603-6_4seq1.xml · derivative · entry 6 Nisita Vittorio · CIK 0001859843 · Head of Global Business Svcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,077 Underlying: Common Stock · 2,077 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. F2 · derivative.exercise_date: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. F2 · derivative.expiration_date: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:49 UTC |
Nisita VittorioHead of Global Business Svcs
|
Tax withholdingCommon Stock | 712 | $32.44 | $23,097.28 |
DisclosureSEC source: 0001104659-22-056630 · tm2214603-6_4seq1.xml · nonDerivative · entry 4 Nisita Vittorio · CIK 0001859843 · Head of Global Business Svcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,005 Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:49 UTC |
Nisita VittorioHead of Global Business Svcs
|
Exercise / conversionCommon Stock | 2,077 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-056630 · tm2214603-6_4seq1.xml · nonDerivative · entry 3 Nisita Vittorio · CIK 0001859843 · Head of Global Business Svcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:48 UTC |
Morrissey Joseph T. Jr.Head of Manufacturing
|
Exercise / conversionRestricted Stock Units · Derivative | 3,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-056629 · tm2214603-5_4seq1.xml · derivative · entry 6 Morrissey Joseph T. Jr. · CIK 0001859805 · Head of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,599 Underlying: Common Stock · 3,599 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. F2 · shares: The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations. F3 · derivative.exercise_date: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. F3 · derivative.expiration_date: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:48 UTC |
Morrissey Joseph T. Jr.Head of Manufacturing
|
Tax withholdingCommon Stock | 1,025 | $32.44 | $33,251.00 |
DisclosureSEC source: 0001104659-22-056629 · tm2214603-5_4seq1.xml · nonDerivative · entry 4 Morrissey Joseph T. Jr. · CIK 0001859805 · Head of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,315 Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:48 UTC |
Morrissey Joseph T. Jr.Head of Manufacturing
|
Exercise / conversionCommon Stock | 3,599 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-056629 · tm2214603-5_4seq1.xml · nonDerivative · entry 3 Morrissey Joseph T. Jr. · CIK 0001859805 · Head of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:47 UTC |
Milligan SandraHead of Research & Development
|
Exercise / conversionRestricted Stock Units · Derivative | 4,984 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-056628 · tm2214603-4_4seq1.xml · derivative · entry 6 Milligan Sandra · CIK 0001859810 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,984 Underlying: Common Stock · 4,984 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. F2 · shares: The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations. F3 · derivative.exercise_date: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. F3 · derivative.expiration_date: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:47 UTC |
Milligan SandraHead of Research & Development
|
Tax withholdingCommon Stock | 1,806 | $32.44 | $58,586.64 |
DisclosureSEC source: 0001104659-22-056628 · tm2214603-4_4seq1.xml · nonDerivative · entry 4 Milligan Sandra · CIK 0001859810 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,231 Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:47 UTC |
Milligan SandraHead of Research & Development
|
Exercise / conversionCommon Stock | 4,984 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-056628 · tm2214603-4_4seq1.xml · nonDerivative · entry 3 Milligan Sandra · CIK 0001859810 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:46 UTC |
Falcione AaronChief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-056626 · tm2214603-2_4seq1.xml · derivative · entry 6 Falcione Aaron · CIK 0001859803 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,770 Underlying: Common Stock · 2,770 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. F2 · derivative.exercise_date: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. F2 · derivative.expiration_date: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:46 UTC |
Falcione AaronChief Human Resources Officer
|
Tax withholdingCommon Stock | 949 | $32.44 | $30,785.56 |
DisclosureSEC source: 0001104659-22-056626 · tm2214603-2_4seq1.xml · nonDerivative · entry 4 Falcione Aaron · CIK 0001859803 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,563 Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:46 UTC |
Falcione AaronChief Human Resources Officer
|
Exercise / conversionCommon Stock | 2,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-056626 · tm2214603-2_4seq1.xml · nonDerivative · entry 3 Falcione Aaron · CIK 0001859803 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,512 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:45 UTC |
Ali KevinChief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 22,158 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-056625 · tm2214603-1_4seq1.xml · derivative · entry 6 Ali Kevin · CIK 0001859698 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,158 Underlying: Common Stock · 22,158 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. F2 · shares: The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations. F3 · derivative.exercise_date: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. F3 · derivative.expiration_date: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:45 UTC |
Ali KevinChief Executive Officer
|
Tax withholdingCommon Stock | 12,254 | $32.44 | $397,519.76 |
DisclosureSEC source: 0001104659-22-056625 · tm2214603-1_4seq1.xml · nonDerivative · entry 4 Ali Kevin · CIK 0001859698 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,913 Read SEC document |
| May 04, 2022 Filed May 6, 2022 00:45 UTC |
Ali KevinChief Executive Officer
|
Exercise / conversionCommon Stock | 22,158 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-056625 · tm2214603-1_4seq1.xml · nonDerivative · entry 3 Ali Kevin · CIK 0001859698 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 04, 2022 Filed May 11, 2022 20:58 UTC |
DiMarco KathrynCorporate Controller
|
Exercise / conversionRestricted Stock Units · Derivative | 1,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-058956 · tm2215313-1_4seq1.xml · derivative · entry 3 DiMarco Kathryn · CIK 0001861045 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,246 Underlying: Common Stock · 1,246 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. F2 · shares: The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations. F3 · derivative.exercise_date: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. F3 · derivative.expiration_date: On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. Read SEC document |
| May 04, 2022 Filed May 11, 2022 20:58 UTC |
DiMarco KathrynCorporate Controller
|
Tax withholdingCommon Stock | 427 | $32.44 | $13,851.88 |
DisclosureSEC source: 0001104659-22-058956 · tm2215313-1_4seq1.xml · nonDerivative · entry 2 DiMarco Kathryn · CIK 0001861045 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,746 Read SEC document |
| May 04, 2022 Filed May 11, 2022 20:58 UTC |
DiMarco KathrynCorporate Controller
|
Exercise / conversionCommon Stock | 1,246 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-058956 · tm2215313-1_4seq1.xml · nonDerivative · entry 1 DiMarco Kathryn · CIK 0001861045 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 03, 2022 Filed May 5, 2022 20:47 UTC |
Fiedler SusanneChief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-056627 · tm2214603-3_4seq1.xml · derivative · entry 5 Fiedler Susanne · CIK 0001859994 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,579 Underlying: Common Stock · 1,579 shares Expires 2022-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. F2 · derivative.exercise_date: The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations. F2 · derivative.expiration_date: The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations. Read SEC document |
| May 03, 2022 Filed May 5, 2022 20:47 UTC |
Fiedler SusanneChief Commercial Officer
|
Tax withholdingCommon Stock | 743 | $32.08 | $23,835.44 |
DisclosureSEC source: 0001104659-22-056627 · tm2214603-3_4seq1.xml · nonDerivative · entry 2 Fiedler Susanne · CIK 0001859994 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,525 Read SEC document |
| May 03, 2022 Filed May 5, 2022 20:47 UTC |
Fiedler SusanneChief Commercial Officer
|
Exercise / conversionCommon Stock | 1,579 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-056627 · tm2214603-3_4seq1.xml · nonDerivative · entry 1 Fiedler Susanne · CIK 0001859994 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,268 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:50 UTC |
Ritter Geralyn SHd of Ext. Affairs and ESG
|
Exercise / conversionRestricted Stock Units · Derivative | 684 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-056631 · tm2214603-7_4seq1.xml · derivative · entry 5 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 684 Underlying: Common Stock · 684 shares Expires 2022-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:50 UTC |
Ritter Geralyn SHd of Ext. Affairs and ESG
|
Tax withholdingCommon Stock | 235 | $32.08 | $7,538.80 |
DisclosureSEC source: 0001104659-22-056631 · tm2214603-7_4seq1.xml · nonDerivative · entry 2 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,752 Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:50 UTC |
Ritter Geralyn SHd of Ext. Affairs and ESG
|
Exercise / conversionCommon Stock | 684 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-056631 · tm2214603-7_4seq1.xml · nonDerivative · entry 1 Ritter Geralyn S · CIK 0001859678 · Hd of Ext. Affairs and ESG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:49 UTC |
Nisita VittorioHead of Global Business Svcs
|
Exercise / conversionRestricted Stock Units · Derivative | 631 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-056630 · tm2214603-6_4seq1.xml · derivative · entry 5 Nisita Vittorio · CIK 0001859843 · Head of Global Business Svcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 631 Underlying: Common Stock · 631 shares Expires 2022-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:49 UTC |
Nisita VittorioHead of Global Business Svcs
|
Tax withholdingCommon Stock | 217 | $32.08 | $6,961.36 |
DisclosureSEC source: 0001104659-22-056630 · tm2214603-6_4seq1.xml · nonDerivative · entry 2 Nisita Vittorio · CIK 0001859843 · Head of Global Business Svcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,640 Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:49 UTC |
Nisita VittorioHead of Global Business Svcs
|
Exercise / conversionCommon Stock | 631 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-056630 · tm2214603-6_4seq1.xml · nonDerivative · entry 1 Nisita Vittorio · CIK 0001859843 · Head of Global Business Svcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:48 UTC |
Morrissey Joseph T. Jr.Head of Manufacturing
|
Exercise / conversionRestricted Stock Units · Derivative | 2,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-056629 · tm2214603-5_4seq1.xml · derivative · entry 5 Morrissey Joseph T. Jr. · CIK 0001859805 · Head of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,807 Underlying: Common Stock · 2,807 shares Expires 2022-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:48 UTC |
Morrissey Joseph T. Jr.Head of Manufacturing
|
Tax withholdingCommon Stock | 800 | $32.08 | $25,664.00 |
DisclosureSEC source: 0001104659-22-056629 · tm2214603-5_4seq1.xml · nonDerivative · entry 2 Morrissey Joseph T. Jr. · CIK 0001859805 · Head of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,741 Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:48 UTC |
Morrissey Joseph T. Jr.Head of Manufacturing
|
Exercise / conversionCommon Stock | 2,807 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-056629 · tm2214603-5_4seq1.xml · nonDerivative · entry 1 Morrissey Joseph T. Jr. · CIK 0001859805 · Head of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:47 UTC |
Milligan SandraHead of Research & Development
|
Exercise / conversionRestricted Stock Units · Derivative | 1,842 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-056628 · tm2214603-4_4seq1.xml · derivative · entry 5 Milligan Sandra · CIK 0001859810 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,842 Underlying: Common Stock · 1,842 shares Expires 2022-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:47 UTC |
Milligan SandraHead of Research & Development
|
Tax withholdingCommon Stock | 525 | $32.08 | $16,842.00 |
DisclosureSEC source: 0001104659-22-056628 · tm2214603-4_4seq1.xml · nonDerivative · entry 2 Milligan Sandra · CIK 0001859810 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,053 Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:47 UTC |
Milligan SandraHead of Research & Development
|
Exercise / conversionCommon Stock | 1,842 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-056628 · tm2214603-4_4seq1.xml · nonDerivative · entry 1 Milligan Sandra · CIK 0001859810 · Head of Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:46 UTC |
Falcione AaronChief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 871 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-056626 · tm2214603-2_4seq1.xml · derivative · entry 5 Falcione Aaron · CIK 0001859803 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 871 Underlying: Common Stock · 871 shares Expires 2022-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:46 UTC |
Falcione AaronChief Human Resources Officer
|
Tax withholdingCommon Stock | 299 | $32.08 | $9,591.92 |
DisclosureSEC source: 0001104659-22-056626 · tm2214603-2_4seq1.xml · nonDerivative · entry 2 Falcione Aaron · CIK 0001859803 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,742 Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:46 UTC |
Falcione AaronChief Human Resources Officer
|
Exercise / conversionCommon Stock | 871 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-056626 · tm2214603-2_4seq1.xml · nonDerivative · entry 1 Falcione Aaron · CIK 0001859803 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:45 UTC |
Ali KevinChief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,631 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-056625 · tm2214603-1_4seq1.xml · derivative · entry 5 Ali Kevin · CIK 0001859698 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,631 Underlying: Common Stock · 2,631 shares Expires 2022-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:45 UTC |
Ali KevinChief Executive Officer
|
Tax withholdingCommon Stock | 1,270 | $32.08 | $40,741.60 |
DisclosureSEC source: 0001104659-22-056625 · tm2214603-1_4seq1.xml · nonDerivative · entry 2 Ali Kevin · CIK 0001859698 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,009 Read SEC document |
| May 03, 2022 Filed May 6, 2022 00:45 UTC |
Ali KevinChief Executive Officer
|
Exercise / conversionCommon Stock | 2,631 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-056625 · tm2214603-1_4seq1.xml · nonDerivative · entry 1 Ali Kevin · CIK 0001859698 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,279 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.